New York State’s Wadsworth Lab And NYC’s Public-Health Lab Win Go-Ahead For COVID-19 Testing
Executive Summary
The US FDA on 29 February approved New York State’s and New York City’s combined Emergency Use Authorization request to conduct coronavirus testing at the state’s Wadsworth Center laboratory in Albany, and its NYC public-health department-based lab. Both sites are CLIA-certified to proceed using COVID-19 laboratory-developed tests, the FDA’s Tim Stenzel said during a 2 March webinar on virus testing.
You may also be interested in...
FDA Issues Revised Reauthorization Of CDC COVID-19 Test, OK’s Change To New York Test
The US agency issued a revised version of an Emergency Use Authorization (EUA) to the Centers for Disease Control and Prevention for the CDC’s COVID-19 test on 15 March, and approved an amendment to New York State’s EUA for its assay on the same day.
LabCorp Launches COVID-19 Testing, Quest Diagnostics Will Provide Testing Starting 9 March In US
LabCorp and Quest announced they will offer testing to detect COVID-19 to address the public health crisis.
COVID-19: FDA Eases Approval Policy By Allowing LDT Use Under ‘Immediately In Effect’ Guidance
The US FDA on 29 February issued a new guidance giving the OK to labs with pending COVID-19 laboratory-developed tests (LDTs) to use them while they await the agency’s approval under Emergency Use Authorization. The agency issued the guidance quickly, taking the unusual step of forgoing a public comment period.